Nuvalent

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Nuvalent and other ETFs, options, and stocks.

About NUVL

Nuvalent, Inc. is a clinical stage biopharmaceutical company, which focuses on creating precisely targeted therapies for patients with cancer. Its pipeline includes ROS1 NSCLC, ALK NSCLC and HER2 NSCLC.

CEO

James R. Porter

CEOJames R. Porter

Employees

Employees92

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2017

Founded2017

Employees

Employees92

NUVL Key Statistics

Market cap

4.28B

Market cap4.28B

Price-Earnings ratio

-30.94

Price-Earnings ratio-30.94

Dividend yield

—

Dividend yield—

Average volume

571.31K

Average volume571.31K

High today

$66.90

High today$66.90

Low today

$65.11

Low today$65.11

Open price

$66.66

Open price$66.66

Volume

230.26K

Volume230.26K

52 Week high

$89.39

52 Week high$89.39

52 Week low

$33.03

52 Week low$33.03

Analyst ratings

100%

of 10 ratings

Buy

100%

Hold

Sell

Nuvalent

Why Robinhood?

Nuvalent, Inc. is a clinical stage biopharmaceutical company, which focuses on creating precisely targeted therapies for patients with cancer. Its pipeline includes ROS1 NSCLC, ALK NSCLC and HER2 NSCLC. Show more

NUVL Key Statistics

Analyst ratings

100%

Nuvalent, Inc. is a clinical stage biopharmaceutical company, which focuses on creating precisely targeted therapies for patients with cancer. Its pipeline includes ROS1 NSCLC, ALK NSCLC and HER2 NSCLC.